Condensed Statements Of Cash Flows - USD ($)	1 Months Ended	3 Months Ended			4 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)		$ 27,525,497	$ 35,901,386	$ (55,850,310)	$ (55,860,934)	$ 78,912,013
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Change in fair value of derivative liability					893,835	(78,251,009)
Financing expense on derivative liabilities				54,956,475	54,956,475
Interest on marketable securities held in Trust Account		(1,297,684)				(1,714,865)
Changes in operating assets and liabilities:
Accounts payable and accrued expenses					10,624	(30,239)
Prepaid expenses						640,181
Net cash used in operating activities						(443,919)
Cash flows from financing activities:
Proceeds from issuance of promissory payable - related party					300,000
Proceeds from issuance of Class L ordinary shares to Sponsor					25,000
Payments of deferred offering costs included in accrued expenses					(319,220)
Prepaid stock subscription					9,750,000
Net cash provided by financing activities					9,755,780
Net change in cash and restricted cash					9,755,780	(443,919)
Cash and restricted cash, beginning of the period			$ 1,259,439			1,259,439
Cash and restricted cash, end of the period	$ 815,520	815,520		$ 9,755,780	9,755,780	815,520
Supplemental disclosure of noncash activities:
Deferred offering costs included in accrued offering costs					$ 578,141
Accretion of Class A ordinary shares redemption value						1,714,865
Waiver deferred underwriting discounts and commissions	$ 2,515,625	$ 2,515,625				$ 2,515,625